Economic benefits of inactivated influenza vaccines in the prevention of seasonal influenza in children

References

• Muñoz FM. The impact of influenza in children. Semin Pediatr Infect Dis 2002; 13:72 - 8; http://dx.doi.org/10.1053/spid.2002.122992; PMID: 12122955
   PubMedGoogle Scholar
• Heikkinen T, Silvennoinen H, Peltola V, Ziegler T, Vainionpaa R, Vuorinen T, et al. Burden of influenza in children in the community. J Infect Dis 2004; 190:1369 - 73; http://dx.doi.org/10.1086/424527; PMID: 15378427
   PubMed Web of Science ®Google Scholar
• Bridges CB, Fukuda K, Uyeki TM, Cox NJ, Singleton JA, Centers for Disease Control and Prevention, Advisory Committee on Immunization Practices. Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2002; 51:RR-3 1 - 31; PMID: 12002171
   PubMedGoogle Scholar
• Smith NM, Bresee JS, Shay DK, Uyeki TM, Cox NJ, Strikas RA, Advisory Committee on Immunization Practices. Prevention and Control of Influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2006; 55:RR-10 1 - 42; PMID: 16874296
   PubMedGoogle Scholar
• CDC. Recommended immunization schedules for persons aged 0-18 years – United States, 2008. MMWR 2008; 57:Q1 - 4
   PubMedGoogle Scholar
• Fiore AE, Uyeki TM, Broder K, Finelli L, Euler GL, Singleton JA, et al, Centers for Disease Control and Prevention (CDC). Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep 2010; 59:RR-8 1 - 62; PMID: 20689501
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention (CDC). Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP)–United States, 2012-13 influenza season. MMWR Morb Mortal Wkly Rep 2012; 61:613 - 8; PMID: 22895385
   PubMedGoogle Scholar
• National Advisory Committee on Immunization (NACI). Statement on seasonal trivalent inactivated influenza vaccine (TIV) for 2010-2011. CCDR 2010; 36(ACS-6):1.
   Google Scholar
• Usonis V, Anca I, André F, Chlibek R, Ivaskeviciene I, Mangarov A, et al, Central European Vaccination Advisory Group. Central European Vaccination Advisory Group (CEVAG) guidance statement on recommendations for influenza vaccination in children. BMC Infect Dis 2010; 10:168; http://dx.doi.org/10.1186/1471-2334-10-168; PMID: 20546586
   PubMed Web of Science ®Google Scholar
• Mereckiene J, Cotter S, D’Ancona F, Giambi C, Nicoll A, Levy-Bruhl D, et al. Differences in national influenza vaccination polices across the European Union. Norway and Iceland 2008-2009. Euro Surveill 2010; 15:pii: 19700; PMID: 21087586
   PubMedGoogle Scholar
• Neuzil KM, Jackson LA, Nelson J, Klimov A, Cox N, Bridges CB, et al. Immunogenicity and reactogenicity of 1 versus 2 doses of trivalent inactivated influenza vaccine in vaccine-naive 5-8-year-old children. J Infect Dis 2006; 194:1032 - 9; http://dx.doi.org/10.1086/507309; PMID: 16991077
   PubMed Web of Science ®Google Scholar
• Zangwill KM, Belshe RB. Safety and efficacy of trivalent inactivated influenza vaccine in young children: a summary for the new era of routine vaccination. Pediatr Infect Dis J 2004; 23:189 - 97; http://dx.doi.org/10.1097/01.inf.0000116292.46143.d6; PMID: 15014289
   PubMed Web of Science ®Google Scholar
• Jefferson T, Smith S, Demicheli V, Harnden A, Rivetti A, Di Pietrantonj C. Assessment of the efficacy and effectiveness of influenza vaccines in healthy children: systematic review. Lancet 2005; 365:773 - 80; PMID: 15733718
   PubMed Web of Science ®Google Scholar
• Negri E, Colombo C, Giordano L, Groth N, Apolone G, La Vecchia C. Influenza vaccine in healthy children: a meta-analysis. Vaccine 2005; 23:2851 - 61; http://dx.doi.org/10.1016/j.vaccine.2004.11.053; PMID: 15780733
   PubMed Web of Science ®Google Scholar
• Vesikari T, Knuf M, Wutzler P, Karvonen A, Kieninger-Baum D, Schmitt HJ, et al. Oil-in-water emulsion adjuvant with influenza vaccine in young children. N Engl J Med 2011; 365:1406 - 16; http://dx.doi.org/10.1056/NEJMoa1010331; PMID: 21995388
   PubMed Web of Science ®Google Scholar
• Salleras L, Domínguez A, Pumarola T, Prat A, Marcos MA, Garrido P, et al. Effectiveness of virosomal subunit influenza vaccine in preventing influenza-related illnesses and its social and economic consequences in children aged 3-14 years: a prospective cohort study. Vaccine 2006; 24:6638 - 42; http://dx.doi.org/10.1016/j.vaccine.2006.05.034; PMID: 16842892
   PubMed Web of Science ®Google Scholar
• Salleras L, Navas E, Domínguez A. Evaluación de la eficiencia de los programas de vacunaciones. In: Salleras L, editor. Vacunaciones preventivas. Barcelona: Masson, 2003: 802-811.
   Google Scholar
• White T, Lavoie S, Nettleman MD. Potential cost savings attributable to influenza vaccination of school-aged children. Pediatrics 1999; 103:e73; http://dx.doi.org/10.1542/peds.103.6.e73; PMID: 10353970
   PubMedGoogle Scholar
• Cohen GM, Nettleman MD. Economic impact of influenza vaccination in preschool children. Pediatrics 2000; 106:973 - 6; http://dx.doi.org/10.1542/peds.106.5.973; PMID: 11061762
   PubMed Web of Science ®Google Scholar
• Dayan GH, Nguyen VH, Debbag R, Gómez R, Wood SC. Cost-effectiveness of influenza vaccination in high-risk children in Argentina. Vaccine 2001; 19:4204 - 13; http://dx.doi.org/10.1016/S0264-410X(01)00160-8; PMID: 11457546
   PubMed Web of Science ®Google Scholar
• Pisu M, Meltzer MI, Hurwitz ES, Haber M. Household-based costs and benefits of vaccinating healthy children in daycare against influenza virus: results from a pilot study. Pharmacoeconomics 2005; 23:55 - 67; http://dx.doi.org/10.2165/00019053-200523010-00005; PMID: 15693728
   PubMed Web of Science ®Google Scholar
• Weycker D, Edelsberg J, Halloran ME, Longini IM Jr., Nizam A, Ciuryla V, et al. Population-wide benefits of routine vaccination of children against influenza. Vaccine 2005; 23:1284 - 93; http://dx.doi.org/10.1016/j.vaccine.2004.08.044; PMID: 15652671
   PubMed Web of Science ®Google Scholar
• Meltzer MI, Neuzil KM, Griffin MR, Fukuda K. An economic analysis of annual influenza vaccination of children. Vaccine 2005; 23:1004 - 14; http://dx.doi.org/10.1016/j.vaccine.2004.07.040; PMID: 15620473
   PubMed Web of Science ®Google Scholar
• Salo H, Kilpi T, Sintonen H, Linna M, Peltola V, Heikkinen T. Cost-effectiveness of influenza vaccination of healthy children. Vaccine 2006; 24:4934 - 41; http://dx.doi.org/10.1016/j.vaccine.2006.03.057; PMID: 16678945
   PubMed Web of Science ®Google Scholar
• Prosser LA, Bridges CB, Uyeki TM, Hinrichsen VL, Meltzer MI, Molinari NA, et al. Health benefits, risks, and cost-effectiveness of influenza vaccination of children. Emerg Infect Dis 2006; 12:1548 - 58; http://dx.doi.org/10.3201/eid1210.051015; PMID: 17176570
   PubMed Web of Science ®Google Scholar
• Marchetti M, Kühnel UM, Colombo GL, Esposito S, Principi N. Cost-effectiveness of adjuvanted influenza vaccination of healthy children 6 to 60 months of age. Hum Vaccin 2007; 3:14 - 22; http://dx.doi.org/10.4161/hv.3.1.3657; PMID: 17245134
   PubMed Web of Science ®Google Scholar
• Skowronski DM, Woolcott JC, Tweed SA, Brunham RC, Marra F. Potential cost-effectiveness of annual influenza immunization for infants and toddlers: experience from Canada. Vaccine 2006; 24:4222 - 32; http://dx.doi.org/10.1016/j.vaccine.2005.12.036; PMID: 16423432
   PubMed Web of Science ®Google Scholar
• Esposito S, Marchisio P, Bosis S, Lambertini L, Claut L, Faelli N, et al. Clinical and economic impact of influenza vaccination on healthy children aged 2-5 years. Vaccine 2006; 24:629 - 35; http://dx.doi.org/10.1016/j.vaccine.2005.08.054; PMID: 16157429
   PubMed Web of Science ®Google Scholar
• Navas E, Salleras L, Domínguez A, Ibáñez D, Prat A, Sentís J, et al. Cost-effectiveness analysis of inactivated virosomal subunit influenza vaccination in children aged 3-14 years from the provider and societal perspectives. Vaccine 2007; 25:3233 - 9; http://dx.doi.org/10.1016/j.vaccine.2007.01.038; PMID: 17324489
   PubMed Web of Science ®Google Scholar
• Salleras L, Navas E, Domínguez A, Ibáñez D, Prat A, Garrido P, et al. Economic benefits for the family of inactivated subunit virosomal influenza vaccination of healthy children aged 3-14 years during the annual health examination in private paediatric offices. Vaccine 2009; 27:3454 - 8; http://dx.doi.org/10.1016/j.vaccine.2009.01.053; PMID: 19200830
   PubMed Web of Science ®Google Scholar
• Savidan E, Chevat C, Marsh G. Economic evidence of influenza vaccination in children. Health Policy 2008; 86:142 - 52; http://dx.doi.org/10.1016/j.healthpol.2007.09.009; PMID: 18054109
   PubMed Web of Science ®Google Scholar
• Nichol K. Cost-effectiveness and socioeconomic aspects of childhood influenza vaccination. Vaccine 2011; 29:7554 - 8; http://dx.doi.org/10.1016/j.vaccine.2011.08.015
   PubMed Web of Science ®Google Scholar
• Newall AT, Jit M, Beutels P. Economic evaluations of childhood influenza vaccination: a critical review. Pharmacoeconomics 2012; 30:647 - 60; http://dx.doi.org/10.2165/11599130-000000000-00000; PMID: 22788257
   PubMed Web of Science ®Google Scholar
• Esposito S, Marchisio P, Cavagna R, Gironi S, Bosis S, Lambertini L, et al. Effectiveness of influenza vaccination of children with recurrent respiratory tract infections in reducing respiratory-related morbidity within the households. Vaccine 2003; 21:3162 - 8; http://dx.doi.org/10.1016/S0264-410X(03)00253-6; PMID: 12804844
   PubMed Web of Science ®Google Scholar
• Gruber WC, Taber LH, Glezen WP, Clover RD, Abell TD, Demmler RW, et al. Live attenuated and inactivated influenza vaccine in school-age children. Am J Dis Child 1990; 144:595 - 600; PMID: 2330929
   PubMedGoogle Scholar
• Hurwitz ES, Haber M, Chang A, Shope T, Teo S, Ginsberg M, et al. Effectiveness of influenza vaccination of day care children in reducing influenza-related morbidity among household contacts. JAMA 2000; 284:1677 - 82; http://dx.doi.org/10.1001/jama.284.13.1677; PMID: 11015798
   PubMed Web of Science ®Google Scholar
• Colombo C, Argiolas L, La Vecchia C, Negri E, Meloni G, Meloni T. Influenza vaccine in healthy preschool children. Rev Epidemiol Sante Publique 2001; 49:157 - 62; PMID: 11319482
   PubMed Web of Science ®Google Scholar
• Jordan R, Connock M, Albon E, Fry-Smith A, Olowokure B, Hawker J, et al. Universal vaccination of children against influenza: are there indirect benefits to the community? A systematic review of the evidence. Vaccine 2006; 24:1047 - 62; http://dx.doi.org/10.1016/j.vaccine.2005.09.017; PMID: 16298026
   PubMed Web of Science ®Google Scholar
• Loeb M, Russell ML, Moss L, Fonseca K, Fox J, Earn DJ, et al. Effect of influenza vaccination of children on infection rates in Hutterite communities: a randomized trial. JAMA 2010; 303:943 - 50; http://dx.doi.org/10.1001/jama.2010.250; PMID: 20215608
   PubMed Web of Science ®Google Scholar
• Salleras L, Domínguez A, Borrás E, Soldevila N. Eficacia protectora de las vacunas y efectividad de las vacunaciones: introducción en la medición de la protección directa e indirecta. Vacunas 2011; 12:136 - 46; http://dx.doi.org/10.1016/S1576-9887(11)70021-8
   Google Scholar
• Borràs E, Domínguez A, Salleras L. [Assessing the effectiveness of vaccination programs]. Gac Sanit 2011; 25:Suppl 1 49 - 55; PMID: 22055551
   PubMedGoogle Scholar
• Simonsen L. Available evidence points to low effectiveness of influenza vaccines for older people. Evid Based Med 2010; 15:109 - 10; http://dx.doi.org/10.1136/ebm1096; PMID: 20570947
   PubMedGoogle Scholar
• Haddix AC, Teutsch SM, Shaffer PA, Duñet DO. Prevention effectiveness: a guide to decision analysis and economic evaluation. New York: Oxford University Press; 1996:12-26.
   Google Scholar
• Schwartz B, Messonier ML. Economic analyses of vaccines and vaccination programs. In: Levine MN, editor. New generation vaccines. Fourth Edition. New York: Informa Healthcare; 2009:107-15.
   Google Scholar